In conclusion, our findings unveil a novel mechanism of chemoresistance in lung cancer cells that involves O-GlcNAcylation of p53 and c-Myc, which in turn interferes with their ubiquitin-proteasomal degradation. This evidence concerns the gene TP53 and lung cancer.